Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: Possible involvement of cell adhesion inhibition

Japanese Journal of Cancer Research

Volumn 88, Issue 1, 1997, Pages 26-33

  Saijo, Yasuo ^a   Uchiyama, Bine ^a   Abe, Tatsuya ^a   Satoh, Ken ^a   Nukiwa, Toshihiro ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Adhesion inhibition; c myc antisense oligonucleotide; Contiguous four guanosine (4G) sequence

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GUANOSINE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CONTROLLED STUDY; DNA SEQUENCE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG SMALL CELL CANCER; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSLATION INITIATION;

EID: 0031051928     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00297.x     Document Type: Article

References (35)

1. Amecnik, P. C. and Stephenson, M. L. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl Acad. Sci. USA, 75, 280-284 (1978).
2. Wagner, R. W. Gene inhibition using antisense oligodeoxynucleotides. Nature, 372, 333-335 (1994).
3. Perlaky, L., Saijo, Y., Busch, R. K., Bennett, C. F., Mirabelli, C. K., Crook, S. K. and Busch, H. Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expression. Anti-Cancer Drug Des., 8, 3-14 (1993).
4. Skorski, T., Nieborowska-Skorska, M., Campbell, K., Iozzo, R. V., Zon, G., Darzynkiewicz, Z. and Calabretta, B. Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes. J. Exp. Med., 182, 1645-1653 (1995).
5. Saijo, Y., Perlaky, L., Valdez, B. C., Wang, H., Henning, D. and Busch, H. Cellular pharmacology of p 120 antisense oligodeoxynucleotide phosphorothioate ISIS 3466. Oncol. Res., 5, 283-291 (1993).
6. Saijo, Y., Perlaky, L., Wang, H. and Busch, H. Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice. Oncol. Res., 6, 243-249 (1994).
7. Stein, C. A. Does antisense exist? Nat. Med., 1, 1119-1121 (1995).
8. Stein, C. A., Neckers, L. M., Nair, B. C., Mumbauer, S., Hoke, G. and Pal, R. Phosphorothioate oligodeoxynucleotide interferes with the binding of HIV-1 gp120 to CD4. J. Acquired Immune Defic. Syndr., 4, 686-693 (1991).
9. Yakubov, L., Khaled, Z., Zhang, L., Truneh, A., Vlassov, V. and Stein, C. A. Oligodeoxynucleotides interact with recombinant CD4 at multiple sites. J. Biol. Chem., 268, 18818-18823 (1993).
10. Perez, J. R., Li, Y., Stein, C. A., Majumder, S., van Oorschot, A. and Narayanan, R. Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA, 91, 5957-5961 (1994).
11. Biro, S., Fu, Y.-M, Yu, Z.-X. and Epstein, S. E. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc. Natl. Acad. Sci. USA, 90, 654-658 (1993).
12. Kimura, S., Maekawa, T., Hirakawa, K., Murakami, A. and Abe, T. Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells. Cancer Res., 55, 1379-1384 (1995).
13. Watson, P. H., Pon, R. T. and Shiu, P. C. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Res., 51, 3996-4000 (1991).
14. Thulasi, R., Harbour, D. V. and Thompson, E. B. Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis. J. Biol. Chem., 268, 18306-18312 (1993).
15. Cerutti, J., Trapasso, F., Battaglia, C., Zhang, L., Martelli, M. L., Visconti, R., Berlingieri, M. T., Fagin, J. A., Santoro, M. and Fusco, A. Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines. Clin. Cancer Res., 2, 119-126 (1996).
16. Burgess, T. L., Fisher, E. F., Ross, S. L., Bready, J. V., Qian, Y.-X., Bayewitch, L. A. and Cohen, A. M. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. USA, 92, 4051-4055 (1995).
17. Gazzeri, S., Brambilla, E., Fromentel, C. C., Gouyer, V., Moro, D., Perron, P., Berger, F. and Brambilla, C. p53 genetic abnormalities and myc activation in human lung carcinoma. Int. J. Cancer, 58, 24-32 (1994).
18. Chiang, M. Y., Chan, H., Zounes, M. A., Freier, S. M., Lima, W. F. and Bennett, C. F. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem., 266, 18162-18171 (1991).
19. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685 (1970).
20. Taya, Y., Hosogai, K., Hirohashi, S., Shimosato, Y., Tsuchiya, R., Tsuchida, N., Fushimi, M., Sekiya, T. and Nishimura, S. A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancer. EMBO J., 3, 2943-2946 (1984)
21. Yoshimoto, K., Hirohashi, S. and Sekiya, T. Increased expression of the c-myc gene without gene amplification in human lung cancer and colon cancer cell lines. Jpn. J. Cancer Res., 77, 540-545 (1986).
22. Takahashi, T., Obata, Y., Sekido, Y., Hida, T., Ueda, T., Watanabe, H., Ariyoshi, Y., Sugiura, T. and Takahashi, T. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. Cancer Res., 49, 2683-2688 (1989).
23. Dosaka-Akita, H., Akie, K., Hiroumi, H., Kinoshita, I., Kawakami, Y. and Murakami, A. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer. Cancer Res., 55, 1559-1564 (1995).
24. Storey, A., Oates, D., Banks, L., Crawford, L., and Crook, T. Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16. Nucleic Acids Res., 19, 4109-4114 (1991).
25. Guvakova, M. A., Yakubov, L. A., Vlodavsky, I., Tonkinson, J. L., Stein, C. A. Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J. Biol. Chem., 270, 2620-2627 (1995).
26. Iwamoto, M., Yagami, K., Valle, P. L., Olsen, B. R., Petropoulos, C. L., Ewert, D. L. and Pacifici, M. Expression and role of c-myc in chondrocytes undergoing endochondral ossification. J. Biol. Chem., 268, 9645-9652 (1993).
27. Yamada, T., Hirohashi, S., Shimosato, Y., Kodama, T., Hayashi, S., Ogura, T., Gamou, S. and Shimizu, N. Giant cell carcinomas of the lung producing colony-stimulating factor in vitro and in vivo. Jpn. J. Cancer Res., 76, 967-976 (1985).
28. Watson, P. H., Pon, R. T. and Shiu, R. Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotide. Exp. Cell Res., 202, 391-397 (1992).
29. Perez, J. R., Higgins-Sochaski, K. A., Maltese, J.-Y. and Narayanan, R. Regulation of adhesion and growth of fibrosarcoma cells by NF-κB RelA involves transforming growth factor β. Mol. Cell. Biol., 14, 5326-5332 (1994).
30. Maltese, J.-Y., Sharma, H. W., Vassilev, L. and Narayanan, R. Sequence context of antisense RelA/NF-κB phosphorothioates determines specificity. Nucleic Acids Res., 23, 1146-1151 (1995).
31. Bates, R. C., Lincz, L. F. and Burns, G. F. Involvement of integrins in cell survival. Cancer Metastasis Rev., 14, 191-203 (1995).
32. 2 enzyme activity by phosphorothioate oligonucleotides. Nucleic Acids Res., 22, 3202-3209 (1994).
33. Yaswen, P., Stampfer, M. R., Gohsh, K. and Cohen, J. S. Effect of sequence of thioated oligonucleotides on cultured human epithelial cells. Antisense Res. Dev., 3, 67-77 (1993).
34. Wyatt, J. R., Vickers, T. A., Roberson, J. L., Buckheit, R. W., Klimkait, T., DeBaets, E., Davis, P. W., Rayner, B., Imbach, J. L. and Ecker, D. J. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc. Natl. Acad. Sci. USA, 91, 1356-1360 (1994).
35. 3) forms an asymmetric diagonally looped dimeric quadruplex with guanosine 5-syn-syn-anti and 5-syn-anti-anti W-glycosidic conformations. Proc. Natl. Acad. Sci. USA, 91, 10546-10550 (1994).